Fact CheckerSign in

NCT06797765Completed

Optical Coherence Tomography Angiography in Neurological Disease

Optical Coherence Tomography Angiography in Neurological Disease: A Pilot Study

Source: ClinicalTrials.gov · Last updated 29 May 2026

Brief summary (registry, in English)

Optical Coherence Tomography Angiography (OCTA) is a non-invasive tool that images the neurovascular structures of the eye by using near-infrared light. Previous literature has demonstrated the potential of OCTA as a screening tool in stroke, but its utility in other neurological illness such as intracranial hemorrhage is unclear. Hence, this pilot study will gather preliminary data to support future grant applications to investigate this area more fully by recruiting patients with neurological illness and healthy controls and comparing their OCTA imaging parameters.

Status (registry)
Completed
Study type
Observational
Enrollment
7 (actual)
First submitted
21 Dec 2024
Start date
20 Oct 2024
Primary completion date
20 May 2026
Lead sponsor
University of Texas Southwestern Medical Center
Diseases
Stroke
NCT number
NCT06797765

What you commit to

  • Study type: Observational
  • Participants enrolled: 7
  • From 20 Oct 2024 to the primary completion date, 20 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnancy
  • Non-English speaking
  • GCS motor score less than 6 (i.e. must be able to follow commands)
  • Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Who the study is looking for

  • Age 18 years or older
  • Patient admitted to the neuroscience intensive care unit with a diagnosis of: subarachnoid hemorrhage, intracerebral hemorrhage, intracranial aneurysm (ruptured or unruptured), intracranial vascular malformation, ischemic stroke, seizure disorder, intracranial infection, intracranial tumor(s), inflammatory demyelinating disease, traumatic brain injury and/or neuromuscular respiratory failure OR subjects from the community without major neurologic, cardiovascular, pulmonary or metabolic disease

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UT Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.